Filtered By:
Specialty: Cardiology
Drug: Plavix
Management: Hospitals
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Ticagrelor: A Review of Its Use in Adults with Acute Coronary Syndromes
Abstract
Ticagrelor (Brilique™, Brilinta®), a cyclopentyl-triazolopyrimidine, is an orally active, reversible, and selective adenosine diphosphate (ADP) receptor antagonist indicated for use in patients with acute coronary syndromes (ACS). Ticagrelor has a faster onset of action and provides greater inhibition of platelet aggregation than clopidogrel. In the large well-designed, PLATO study in adult patients with ACS, 12 months’ treatment with ticagrelor was more effective than clopidogrel in reducing the incidence of the primary composite endpoint of myocardial infarction, stroke, or cardiovascular (CV) dea...
Source: American Journal of Cardiovascular Drugs - February 12, 2015 Category: Cardiology Source Type: research
